What they were paid
REGENXBIO Director Compensation Table · all 4 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $52,500 | $68,747 | $206,247 | $0 | $327,494 |
| FY2024 | $65,000 | $206,245 | $68,737 | — | $339,981 |
| FY2022 | $74,750 | $68,748 | $206,249 | — | $349,747 |
| FY2021 | $71,000 | — | $198,438 | — | $269,438 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: REGENXBIO Inc. DEF 14A filed April 14, 2026, accession 0001193125-26-155058, and prior-year filings. Open the filing on EDGAR.
That is A.N. Jerry Karabelas’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.
Saved. One email when A.N. Jerry Karabelas’s next annual disclosure lands here, with the figure.
One email when A.N. Jerry Karabelas’s next annual disclosure is on this page, with the figure. Nothing else is sent.
Get the REGENXBIO Board Governance Report
$327,494 A.N. Jerry Karabelas, FY2025 total director compensation
$499
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 14, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025REGENXBIO pays directors a $45,000 cash retainer and $275,000 in Options and RSUs.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the REGENXBIO board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alexandra Glucksmann | Independent Director | $327,494 |
| Allan M. Fox | Independent Director | $319,994 |
| Curran Simpson | Director | — |
| Daniel Tass | Lead Independent Director | — |
| David C. Stump | Independent Director | $339,994 |
| George Migausky | Independent Director | $339,994 |
| Jean Bennett | Independent Director | $324,994 |
| Jennifer Zachary | Independent Director | $329,994 |
| Kenneth T. Mills | Chair of the Board | $354,994 |
The full REGENXBIO compensation record
free company briefThis page is one director within REGENXBIO's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the REGENXBIO proxy · each links to its own free briefOrder RGNX
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.